Skip to content
Back to Guavy Wire
Stocks

Amgen's 2026 Advocacy Summit Brings Together Global Patient Advocates

Instruments
AMGN
Share

Amgen's Chairman and CEO Bob Bradway welcomed leaders from around the world to the company's 2026 Advocacy Summit. The event brought together advocates who work on behalf of patients and their communities, providing a platform for them to share their perspectives and challenges.

The summit aimed to foster collaboration and understanding between Amgen and its partners in patient advocacy. By listening to and learning from each other, the company hopes to make a meaningful difference for patients worldwide.

Bradway expressed his appreciation for the opportunity to hear directly from the advocates about the communities they serve and the challenges patients continue to face. He emphasized the importance of their perspectives in informing Amgen's work and approach to serving patients.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc